MYX mayne pharma group limited

Sale of retail generics portfolio, page-3

  1. 1,060 Posts.
    lightbulb Created with Sketch. 86
    Announced an on-market share buy-back program for up to 10% of the Company’s issued capital • Under the Corporations Act, Mayne Pharma may buy back up to 10% of issued capital in any 12-month period without shareholder approval • The buy-back will be funded from Mayne Pharma’s current cash reserves • Mayne Pharma’s Board intends to maintain a conservative balance sheet following completion of the buy-back and will continue to assess the merits of this capital management plan as market conditions evolve
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.05
Change
0.000(0.00%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.00 $5.08 $4.80 $1.775M 357.2K

Buyers (Bids)

No. Vol. Price($)
10 5646 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.06 1360 11
View Market Depth
Last trade - 13.23pm 21/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.